The congenital form of thrombotic thrombocytopenic purpura (TTP) is caused by genetic mutations in ADAMTS13. Some, but not all, congenital TTP patients manifest renal insufficiency in addition to microangiopathic hemolysis and thrombocytopenia. We included 32 congenital TTP patients in the present study, which was designed to assess whether congenital TTP patients with renal insufficiency have predisposing mutations in complement regulatory genes, as found in many patients with atypical hemolytic uremic syndrome (aHUS). In 13 patients with severe renal insufficiency, six candidate complement or complement regulatory genes were sequenced and 11 missense mutations were identified. One of these missense mutations, C3:p.K155Q mutation, is a rar...
Background Mutations in complement factor H (CFH), factor I (CFI), factor B (CFB), thrombomodulin (T...
Mutations in complement factor H (CFH), factor I (CFI), factor B (CFB), thrombomodulin (THBD), C3 an...
BACKGROUND: The 2 main forms of thrombotic microangiopathy (TMA) are thrombotic thrombocytopenic pu...
Essentials: The differential diagnosis among thrombotic microangiopathies (TMAs) is challenging. We ...
BACKGROUND: Atypical HUS (aHUS) is thought to be caused by predisposing mutations in genes encoding ...
INTRODUCTION: Complement-mediated atypical hemolytic uremic syndrome (aHUS) is an ultra-rare renal d...
Several abnormalities in complement genes reportedly contribute to atypical hemolytic uremic syndrom...
Background and objectives: Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in...
BACKGROUND: The pentad of thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic sig...
The 2 main forms of thrombotic microangiopathy () are thrombotic thrombocytopenic purpura () and aty...
Atypical hemolytic uremic syndrome (aHUS) is a rare renal thrombotic microangiopathy commonly associ...
BACKGROUND: Mutations in complement factor H (CFH), factor I (CFI), factor B (CFB), thrombomodulin (...
Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by microangiopathic hemoly...
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy (TMA) disorder characterised by the ...
The hemolytic-uremic syndrome consists of the triad of microangiopathic hemolytic anemia, thrombocyt...
Background Mutations in complement factor H (CFH), factor I (CFI), factor B (CFB), thrombomodulin (T...
Mutations in complement factor H (CFH), factor I (CFI), factor B (CFB), thrombomodulin (THBD), C3 an...
BACKGROUND: The 2 main forms of thrombotic microangiopathy (TMA) are thrombotic thrombocytopenic pu...
Essentials: The differential diagnosis among thrombotic microangiopathies (TMAs) is challenging. We ...
BACKGROUND: Atypical HUS (aHUS) is thought to be caused by predisposing mutations in genes encoding ...
INTRODUCTION: Complement-mediated atypical hemolytic uremic syndrome (aHUS) is an ultra-rare renal d...
Several abnormalities in complement genes reportedly contribute to atypical hemolytic uremic syndrom...
Background and objectives: Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in...
BACKGROUND: The pentad of thrombocytopenia, hemolytic anemia, mild renal dysfunction, neurologic sig...
The 2 main forms of thrombotic microangiopathy () are thrombotic thrombocytopenic purpura () and aty...
Atypical hemolytic uremic syndrome (aHUS) is a rare renal thrombotic microangiopathy commonly associ...
BACKGROUND: Mutations in complement factor H (CFH), factor I (CFI), factor B (CFB), thrombomodulin (...
Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by microangiopathic hemoly...
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy (TMA) disorder characterised by the ...
The hemolytic-uremic syndrome consists of the triad of microangiopathic hemolytic anemia, thrombocyt...
Background Mutations in complement factor H (CFH), factor I (CFI), factor B (CFB), thrombomodulin (T...
Mutations in complement factor H (CFH), factor I (CFI), factor B (CFB), thrombomodulin (THBD), C3 an...
BACKGROUND: The 2 main forms of thrombotic microangiopathy (TMA) are thrombotic thrombocytopenic pu...